Skip to content

Anika Therapeutics ANIK Change in Income Taxes

Change in Income Taxes at other companies

Stryker logo
StrykerSYK
$42M-14.3%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
-$7.4M+52.6%
Globus Medical logo
Globus MedicalGMED
$14.58M-25.7%

Other financials

Income statement

See full
Revenue$29.6M+13.2%
Net income-$5.1M-3.8%

Balance sheet

See full
Cash & equivalents$41.0M-23.1%
Total debt$25.7M+1.2%
Total equity$133.9M-9.8%
Total assets$179.4M-5.9%

Cash flow

See full
Operating cash flow-$4.8M-3,628%
CapEx$1.4M-49.3%
Free cash flow-$6.3M-112%

Valuation

See full
Market cap$204.37M+31.6%
Enterprise value$189.09M+48.7%
P/S1.8×+0.1×

Profitability

See full
Net margin-9.8%-4.4pp
FCF margin0.9%

Returns & leverage

See full
Return on equity-8%-3.4pp
Debt / equity0.2×0.0×
Current ratio4.5×-1.3×

Where this comes from

Reported directly by Anika Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable.

The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Anika Therapeutics's change in income taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Anika Therapeutics's change in income taxes?
Anika Therapeutics (ANIK) reported change in income taxes of $1.19M in Q1 2026.
How has Anika Therapeutics's change in income taxes changed year-over-year?
Anika Therapeutics's change in income taxes increased by 9253.8% year-over-year, from -$13K to $1.19M.
What does change in income taxes mean?
Change in income tax receivables and payables, reflecting timing between tax accruals and cash payments.